163 related articles for article (PubMed ID: 31736013)
1. Novel mutations in the QRDR region gyrA gene in multidrug-resistance Corynebacterium spp. isolates from intravenous sites.
Ramos JN; Valadão TB; Baio PVP; Mattos-Guaraldi AL; Vieira VV
Antonie Van Leeuwenhoek; 2020 Apr; 113(4):589-592. PubMed ID: 31736013
[TBL] [Abstract][Full Text] [Related]
2. Wide spread and diversity of mutation in the gyrA gene of quinolone-resistant Corynebacterium striatum strains isolated from three tertiary hospitals in China.
Wang Y; Shi X; Zhang J; Wang Y; Lv Y; Du X; ChaoLuMen Q; Wang J
Ann Clin Microbiol Antimicrob; 2021 Oct; 20(1):71. PubMed ID: 34598679
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream and catheter-related infections due to different clones of multidrug-resistant and biofilm producer Corynebacterium striatum.
Ramos JN; Souza C; Faria YV; da Silva EC; Veras JFC; Baio PVP; Seabra SH; de Oliveira Moreira L; Hirata Júnior R; Mattos-Guaraldi AL; Vieira VV
BMC Infect Dis; 2019 Jul; 19(1):672. PubMed ID: 31357945
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia caused by Corynebacterium amycolatum with a novel mutation in gyrA gene that confers high-level quinolone resistance.
Yoon S; Kim H; Lee Y; Kim S
Korean J Lab Med; 2011 Jan; 31(1):47-8. PubMed ID: 21239871
[TBL] [Abstract][Full Text] [Related]
5. Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum.
Sierra JM; Martinez-Martinez L; Vázquez F; Giralt E; Vila J
Antimicrob Agents Chemother; 2005 May; 49(5):1714-9. PubMed ID: 15855486
[TBL] [Abstract][Full Text] [Related]
6. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites.
Zhang W; Wu Y; Yin W; Yu M
Chin Med J (Engl); 2002 Oct; 115(10):1573-5. PubMed ID: 12490114
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
Urushibara N; Suzaki K; Kawaguchiya M; Aung MS; Shinagawa M; Takahashi S; Kobayashi N
Microb Drug Resist; 2018; 24(1):1-7. PubMed ID: 28504916
[TBL] [Abstract][Full Text] [Related]
8. Genetic mutations in the quinolone resistance-determining region are related to changes in the epidemiological profile of methicillin-resistant Staphylococcus aureus isolates.
de Oliveira TLR; Cavalcante FS; Chamon RC; Ferreira RBR; Dos Santos KRN
J Glob Antimicrob Resist; 2019 Dec; 19():236-240. PubMed ID: 31176072
[TBL] [Abstract][Full Text] [Related]
9. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
McIver C; Hogan T; White P; Tapsall J
Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
[TBL] [Abstract][Full Text] [Related]
10. Genome sequence of a multidrug-resistant Corynebacterium striatum isolated from bloodstream infection from a nosocomial outbreak in Rio de Janeiro, Brazil.
Ramos JN; Rodrigues IDS; Baio PVP; Veras JFC; Ramos RTJ; Pacheco LG; Azevedo VA; Hirata Júnior R; Marín MA; Mattos-Guaraldi AL; Vieira VV
Mem Inst Oswaldo Cruz; 2018 Jul; 113(9):e180051. PubMed ID: 29995109
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics susceptibility of quinolones against Salmonella spp. strains isolated and molecularly sequenced for gyrA gene.
Macías-Farrera GP; de Oca Jiménez RM; Varela-Guerrero J; Tenorio-Borroto E; Rivera-Ramírez F; Monroy-Salazar HG; Yong-Angel G
Microb Pathog; 2018 Jan; 114():286-290. PubMed ID: 29208542
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
13. New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations.
Salehi N; Attaran B; Eskini N; Esmaeili M; Sharifirad A; Sadeghi M; Mohammadi M
Helicobacter; 2019 Oct; 24(5):e12628. PubMed ID: 31282059
[TBL] [Abstract][Full Text] [Related]
14. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
Li Q; Bi X; Diao Y; Deng X
Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
Bogaerts P; Berhin C; Nizet H; Glupczynski Y
Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
[TBL] [Abstract][Full Text] [Related]
17. Detection of gyrA mutation among clinical isolates of Campylobacter jejuni isolated in Egypt by MAMA-PCR.
Said MM; El-Mohamady H; El-Beih FM; Rockabrand DM; Ismail TF; Monteville MR; Ahmed SF; Klena JD; Salama MS
J Infect Dev Ctries; 2010 Oct; 4(9):546-54. PubMed ID: 21045366
[TBL] [Abstract][Full Text] [Related]
18. Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones.
Piccinelli G; Gargiulo F; Biscaro V; Caccuri F; Caruso A; De Francesco MA
Infect Genet Evol; 2017 Jan; 47():64-67. PubMed ID: 27884651
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis].
Misiurina OIu; Shipitsina EV; Finashutina IuP; Lazarev VN; Akopian TA; Savicheva AM; Govorun VM
Mol Gen Mikrobiol Virusol; 2004; (3):3-7. PubMed ID: 15354934
[TBL] [Abstract][Full Text] [Related]
20. Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs.
Kotb DN; Mahdy WK; Mahmoud MS; Khairy RMM
BMC Infect Dis; 2019 Nov; 19(1):979. PubMed ID: 31752702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
